1. ARVO Disclosure Guidelines Presenting Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject matter for all authors of the presentation and their spouse or partner for the prior 24 months. All full disclosures must be indicated orally and on a slide at the beginning of the presentation. A full disclosure will include the name(s) of the commercial interest and the nature of the relationship(s). Indicate “None” if no relationships exist. View the ARVO Commercial Relationships Policy for complete reporting requirements.ARVO Commercial Relationships Policy

2. ARVO Disclosure Codes Definitions F (Financial Support) Indicates financial support received from an ACCME-defined commercial interest, in the form of research funding, grants, research materials or in-kind services (e.g., protein sequencing). I (Personal Financial Interest) Indicates you are an investor in a company or competing company, including an ACCME-defined commercial interest, other than through a mutual or retirement fund. E (Employment) Indicates you are an employee of an ACCME-defined commercial interest. C (Consultant) Indicates you are a consultant for an ACCME-defined commercial interest. P (Patent) Indicates you are an inventor/developer designated on a patent, patent application, copyright, or trade secret, whether or not the patent, copyright, etc. is presently licensed or otherwise commercialized, or could be in competition with the technology described. R (Recipient) Indicates you have received gifts, honoraria, travel reimbursement, patent royalties, or any other financial compensation valued in any amount from an ACCME-defined commercial interest. N (No Commercial Relationship) Indicates there is no commercial relationship relevant to the subject matter of the abstract/article/presentation. S (non-remunerative) Indicates you have position(s) of influence such as officer, board member, trustee, spokesperson, etc.

3. Disclosure Example 1 F (Financial Support): Acme Company (research funding) I (Personal Financial Interest): Cyberdyne Systems Corp. (shareholder) C (Consultant): Stark Industries, Tyrell Corp, Wayne Enterprises (consultant) P (Patent): Cyberdyne Systems Corp. (licensed patents related to cybernetic prostheses) R (Recipient): Cyberdyne Systems Corp. (dividends and royalties) S: Globex, Oscorp, Virtucon (non-remunerated board member)

4. Disclosure Example 2 Acme Company (F), Cyberdyne Systems Corp. (I, P, R), Globex (S), Oscorp (S), Stark Industries (C), Tyrell Corp (C), Virtucon (S), Wayne Enterprises (C)

5. Disclosure Example 3 N: No commercial relationships relevant to the subject matter of the presentation

6. Disclosure Example 4 Commercial Relationships: None